DETROIT, Oct. 10, 2014 (GLOBE NEWSWIRE) -- Covisint Corporation (Nasdaq:COVS) reported that its parent, Compuware Corporation (Nasdaq:CPWR), today announced that its board of directors has approved the distribution of all of its equity interest in Covisint to Compuware shareholders and holders of Compuware restricted stock units (RSU). Compuware announced the distribution will be effective on October 31, 2014 and announced the approximate distribution ratios, record date and other details of the spin-off. When the distribution is complete, Compuware will no longer own any interest in Covisint. "The spin-off is exciting news for Covisint, and marks the beginning of the next stage of Covisint's evolution," said Covisint CEO Sam Inman. "We will continue to focus on building a world-class B2B Cloud Platform company, providing our customers a single point of entry to connect with their business partners and customers to ensure trusted information gets to the right people and place at the right time." Distribution Details The Compuware board of directors has authorized the distribution to Compuware shareholders of all of its shares of Covisint common stock (31,384,920 shares as of today) on October 31, 2014, the distribution date, as a pro rata dividend on shares of Compuware common stock, and on shares of Compuware common stock deliverable under restricted stock units relating to Compuware common stock ("RSUs"), outstanding on October 20, 2014, the record date. Based on the number of Compuware shares outstanding and shares deliverable under RSUs as of October 8, 2014, holders of Compuware common stock are expected to receive approximately 0.1402 shares of Covisint common stock in the distribution with respect to each outstanding share of Compuware common stock they own at the close of business on the record date, and holders of RSUs are expected to receive approximately 0.1402 shares of Covisint common stock in the distribution with respect to each share of Compuware common stock deliverable under the RSUs they hold at the close of business on the record date. The actual distribution ratio for the Covisint common stock to be distributed per share of Compuware common stock and per RSU will be determined based on the actual number of shares of Compuware common stock outstanding on the record date and shares deliverable under RSUs outstanding on the record date.
Fractional shares of Covisint common stock will not be distributed to Compuware shareholders or RSU holders. Instead, the fractional shares of Covisint common stock will be aggregated and sold in the open market, with the net proceeds distributed pro rata in the form of cash payments to Compuware shareholders and RSU holders who would otherwise receive Covisint fractional shares.The spin-off is expected to be taxable for U.S. federal income tax purposes. Thus, the value of the Covisint common stock, as well as any cash received in lieu of fractional shares, will generally be taxable. Compuware shareholders and RSU holders should consult their tax advisors with respect to U.S. federal, state, local and foreign tax consequences of the distribution, including, without limitation, the potential imposition of withholding taxes on the distribution of Covisint common stock. Beginning on October 16, 2014 (the "ex-dividend date"), and continuing through the close of trading on the NASDAQ Global Select Market ("Nasdaq") on October 31, 2014, the distribution date, the following markets will exist in Compuware and Covisint common stock (each of which will be traded on the Nasdaq):
- Compuware common stock "regular way" market (Nasdaq:CPWR): Shares of Compuware common stock that will continue to trade in the regular way market, the same market in which they are currently traded. Beginning October 16, 2014, trades in Compuware common stock will not include any entitlement to shares of Covisint common stock to be distributed pursuant to the distribution. Holders of shares of Compuware common stock who sell Compuware shares, from and after the October 16, 2014 ex-dividend date and through the October 31, 2014 distribution date, will retain their right to receive Covisint shares, unless they separately sell such right in the Covisint "additional shares when issued" market (see below).
- Covisint common stock "regular way" market (Nasdaq:COVS): The regular way market is the same market for Covisint common stock that has been in existence since Covisint commenced its initial public offering of common stock in September 2013.
- Covisint common stock "additional shares when issued" market (Nasdaq:COVS): The additional shares when issued market for Covisint common stock relates to the shares of Covisint common stock that will be distributed to Compuware shareholders on the distribution date. Holders of Compuware shares entitled to receive shares of Covisint common stock in the distribution may separately sell their entitlement to the shares of Covisint common stock beginning October 16, 2014 through October 31, 2014, in the Covisint common stock additional shares when issued trading market.
Compuware common stock trades on Nasdaq under the symbol "CPWR." Covisint common stock trades on Nasdaq under the symbol "COVS."Covisint Corporation Covisint provides a single entry point for business partners and customers to connect with enterprises that ensures trusted information gets to the right people and place at the right time. Covisint's B2B Cloud Platform enables solutions that allow enterprises and industries to solve complex information and user management challenges across Business-to-Partner (B2P), Business-to-Customer (B2C) and Business-to-Enterprise (B2E) relationships. Today, Covisint powers, secures and connects more than 212,000 business partners and customers to some of the world's leading global enterprises across multiple industries. Learn more at www.covisint.com. Follow us:
CONTACT: Investor Relations Contact 866.319.7659 email@example.com Media Contact Brad Schechter 313.961.5290 firstname.lastname@example.org For Sales and Marketing Information Covisint Corporation, One Campus Martius, Detroit, MI 48226, 313-961-4100, http://www.covisint.com